Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Phathom Pharmaceuticals (PHAT) operate in?

Phathom Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Phathom Pharmaceuticals Stock (NASDAQ: PHAT) stock price, news, charts, stock research, profile.

Open	$6.98
Close	$6.96
Volume / Avg.	754.61K / 1.27M
Day Range	$6.78 - $7.05
52 Wk Range	6.07 - 19.71
Market Cap	$492.32M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	30.87%
Days to Cover	14.43

Recent News

Walmart Posts Upbeat Earnings, Joins Armstrong World Industries, Owens & Minor And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were mostly lower, with the Nasdaq Composite falling more than 200 points on Tuesday.

Avi Kapoor

"Top Pick for 2024": Analyst Bullish On Phathom Pharmaceuticals On Voquezna Launch In Erosive GERD, Projecting $55.6M In Sales

Needham analyst Joseph Stringer reiterated a Buy rating on Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT),

Nabaparna Bhattacharya

What's Going On With Phathom Pharmaceuticals Stock?

Phathom Pharmaceuticals Inc (NASDAQ: PHAT) shares are trading higher Monday after the company announced FDA approval of its reformulated vo

Adam Eckert

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul 24

Aug 24

Sep 24

Dec 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$6.98
Close	$6.96
Volume / Avg.	754.61K / 1.27M
Day Range	$6.78 - $7.05
52 Wk Range	6.07 - 19.71
Market Cap	$492.32M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	30.87%
Days to Cover	14.43

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Phathom Pharmaceuticals (PHAT) stock?

You can purchase shares of Phathom Pharmaceuticals (NASDAQ:PHAT) through any online brokerage.

View our list of the best stock brokerages

Who are Phathom Pharmaceuticals (PHAT) competitors?

Other companies in Phathom Pharmaceuticals’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL) and Xeris Biopharma Holdings (NASDAQ:XERS).

What is the forecast, or price target, for Phathom Pharmaceuticals (PHAT) stock?

Phathom Pharmaceuticals has a consensus price target of $23.63.

What is the current price for Phathom Pharmaceuticals (PHAT)?

The stock price for Phathom Pharmaceuticals (NASDAQ: PHAT) is $7.2 last updated January 17, 2025 at 5:02 PM EST.

Does Phathom Pharmaceuticals (PHAT) pay a dividend?

There are no upcoming dividends for Phathom Pharmaceuticals.

When is Phathom Pharmaceuticals (NASDAQ:PHAT) reporting earnings?

Phathom Pharmaceuticals’s Q4 earnings are confirmed for Thursday, March 6, 2025.

Is Phathom Pharmaceuticals (PHAT) going to split?

There is no upcoming split for Phathom Pharmaceuticals.

What sector and industry does Phathom Pharmaceuticals (PHAT) operate in?

Phathom Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Phathom Pharmaceuticals

Phathom Pharmaceuticals (PHAT) Forecast